Avalo Therapeutics (AVTX) Debt Ratio (2014 - 2025)
Avalo Therapeutics posted quarterly Debt Ratio of 0.0 for Q2 2025, up 12.47% on a QoQ basis from 0.0 in Q1 2025.
Avalo Therapeutics (AVTX) has 11 years of Debt Ratio data on file, last reported at 0.0 in Q2 2025.
- For the quarter ending Q2 2025, Debt Ratio changed N/A year-over-year to 0.0; the trailing twelve-month figure through Jun 2025 stood at 0.0 (changed N/A YoY), and the FY2024 full-year result was 0.0, changed N/A from the prior year.
- Debt Ratio for Q2 2025 stood at 0.0, up from 0.0 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.58 in Q2 2022 and bottomed at 0.0 in Q4 2024.
- The 5-year median for Debt Ratio is 0.35 (2022), against an average of 0.27.
- Peak annual rise in Debt Ratio reached 1.26% in 2022, while the deepest fall reached 1.26% in 2022.
- A 5-year view of Debt Ratio shows it stood at 0.41 in 2021, then declined by 1.26% to 0.4 in 2022, then slipped by 28.51% to 0.29 in 2023, then tumbled by 99.17% to 0.0 in 2024, then increased by 22.39% to 0.0 in 2025.
- The last three Debt Ratio figures came in at 0.0 (Q2 2025), 0.0 (Q1 2025), and 0.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.18 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 1.41 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.05 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Mar 31, 2023 | 0.29 |
| Dec 31, 2022 | 0.40 |
| Sep 30, 2022 | 0.45 |
| Jun 30, 2022 | 0.58 |
| Dec 31, 2021 | 0.41 |
| Sep 30, 2019 | 0.27 |
| Jun 30, 2019 | 0.27 |
| Mar 31, 2019 | 0.22 |
| Dec 31, 2018 | 0.22 |
| Sep 30, 2018 | 0.24 |
| Jun 30, 2018 | 0.25 |
| Mar 31, 2018 | 0.24 |
| Jun 30, 2017 | 0.10 |
| Mar 31, 2017 | 0.42 |
| Dec 31, 2016 | 0.41 |
| Sep 30, 2016 | 0.33 |
| Jun 30, 2016 | 0.30 |
| Mar 31, 2016 | 0.28 |
| Dec 31, 2015 | 0.26 |
| Sep 30, 2015 | 1.16 |
| Dec 31, 2014 | 0.59 |